Grupo Sabin S/A

Sabin is the cornerstone of our portfolio and our story. Since 1984, we own a controlling stake at Grupo Sabin S/A, a medical lab test provider in Brazil. Sabin provides diagnostics services focused on clinical lab testing, imaging, primary care, and vaccines. The company provides data insights for patients, doctors, and health insurance, serving 16 hospitals and over 6M patients through its digital channels and 375 patient service centers across 61 cities in Brazil.

Our ownership stake in Sabin is not merely strategic or financial; it's also deeply personal, as it continues a legacy of healthcare excellence initiated by the Costa family. Sabin's dominant position in Brazilian diagnostics — with an integrated platform spanning lab testing, imaging, primary care, and vaccines — provides a durable competitive moat. The structural growth in Brazilian healthcare demand, driven by an aging population and rising preventive care adoption, underpins long-term value creation.

Active controlling stake. Sabin has grown from a single laboratory to one of Brazil's largest diagnostic groups, serving 16 hospitals and over 6M patients through 375 service centers across 61 cities. The company continues expanding its integrated healthcare platform.